NeoDynamics AB, Product Pipeline Analysis, 2019 Update - NeoNavia Biopsy System Helps to Collect Samples from Breast Lesions or Axillary Lymph Nodes for Diagnostic Analysis of Breast Abnormalities - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 20, 2020--
The “NeoDynamics AB - Product Pipeline Analysis, 2019 Update” company profile has been added to ResearchAndMarkets.com’s offering.
NeoDynamics AB (NeoDynamics) is a medical technology company that develops medical solutions for the early detection and treatment of cancer. The company develops the NeoNavia biopsy system that helps to collect samples from breast lesions or axillary lymph nodes for diagnostic analysis of breast abnormalities. Its NeoNavia biopsy system is designed to manage challenges related to axillary lymph node biopsies such as injuring small or large blood vessels, injuring nerves, injuring the thoracic muscles and pneumothorax. The company offers medical solutions to clinicians and physicians. NeoDynamics is headquartered in Stockholm, Sweden.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Reasons to Buy:
Key Topics Covered:
For more information about this company profile visit https://www.researchandmarkets.com/r/dugqqc
View source version on businesswire.com:https://www.businesswire.com/news/home/20200120005301/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH ONCOLOGY MEDICAL DEVICES
SOURCE: Research and Markets
Copyright Business Wire 2020.
PUB: 01/20/2020 09:28 AM/DISC: 01/20/2020 09:28 AM